Skip to content
Screener

Viatris VTRS Finite-Lived Intangible Assets, Accumulated Amortization

Finite-Lived Intangible Assets, Accumulated Amortization at other companies

McKesson logo
McKessonMCK
$2.05B+8.9%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$486.42M+18.8%
Merck & Co. logo
Merck & Co.MRK
$28.73B+11.4%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$12.76M
Pfizer logo
PfizerPFE
AbbVie logo
AbbVieABBV

Other financials

Income statement

See full
Revenue$3.8B+4.9%
Gross profit$1.5B+9.3%
Operating income$6.3M-97.3%
Net income-$118.8M-2,483%
EPS (diluted)-$0.10

Balance sheet

See full
Cash & equivalents$890.0M+56.7%
Total debt$13.6B-7.7%
Total equity$14.3B-8.4%
Total assets$35.0B-8.8%

Cash flow

See full
Operating cash flow$381.8M+73.8%
CapEx$52.8M-0.2%
Free cash flow$329.0M+97.2%

Valuation

See full
Market cap$18.87B+64.2%
Enterprise value$31.61B+23.0%
P/S1.3×+0.5×

Profitability

See full
Gross margin34.8%-1.8pp
Operating margin-0.6%
Net margin-2.8%-1.3pp
FCF margin13.3%+0.9pp

Returns & leverage

See full
Return on equity-2.8%-1.3pp
Debt / equity0.0×
Current ratio1.6×+0.2×

Where this comes from

Reported directly by Viatris in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization.

The source filing: Viatris’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:04 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001792044-26-000041
(In millions) / June 30, 2026Weighted Average Life (Years)Original CostAccumulated AmortizationNet Book Value
Product rights, licenses and other (1)13$33,819.6$20,848.7$12,970.9
In-process research and development706.0706.0
$34,525.6$20,848.7$13,676.9
December 31, 2025
Product rights, licenses and other (1)13$34,506.8$20,110.7$14,396.1
In-process research and development706.0706.0
$35,212.8$20,110.7$15,102.1

ITEM 6. [Exhibits](#i61e5533529bd4b8b8b580f5cad6a41ec_190) [74](#i61e5533529bd4b8b8b580f5cad6a41ec_190)

FAQ

What is Viatris's finite-lived intangible assets, accumulated amortization?
Viatris (VTRS) reported finite-lived intangible assets, accumulated amortization of $20.85B in Q2 2026.
How has Viatris's finite-lived intangible assets, accumulated amortization changed year-over-year?
Viatris's finite-lived intangible assets, accumulated amortization increased by 7.6% year-over-year, from $19.38B to $20.85B.
What is the long-term trend for Viatris's finite-lived intangible assets, accumulated amortization?
Over 5 years (2020 to 2025), Viatris's finite-lived intangible assets, accumulated amortization has grown at a 13.2% compound annual growth rate (CAGR), from $10.8B to $20.11B.
What does finite-lived intangible assets, accumulated amortization mean?
Finite-Lived Intangible Assets, Accumulated Amortization

Ask your AI about Viatris's finite-lived intangible assets, accumulated amortization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude